Stellungnahme der europäischen Arzneimittelagentur (EMA) zu Hydroxyethylstärke (HES)

PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients